Keke Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Pluripotent Stem Cells

Dna Methylation

Histone Deacetylase

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Cell death discovery

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Xinxing Wan, Linghao Wang, Md Asaduzzaman Khan, Lin Peng, Keke Zhang, Xiaoying Sun, Xuan Yi, Zhouqi Wang, Ke Chen
Shift work promotes adipogenesis via cortisol-dependent downregulation of EGR3-HDAC6 pathway. Cell death discovery 10 (1) (2024)
Xinxing Wan, Linghao Wang, Md Asaduzzaman Khan, Lin Peng, Keke Zhang, Xiaoying Sun, Xuan Yi, Zhouqi Wang, Ke Chen
Shift work promotes adipogenesis via cortisol-dependent downregulation of EGR3-HDAC6 pathway. Cell death discovery 10 (1) (2024)
Xiaoying Sun, Xinxing Wan, Md Asaduzzaman Khan, Keke Zhang, Xuan Yi, Zhouqi Wang, Ke Chen
Comprehensive Analysis of circRNA Expression Profiles in Human Brown Adipose Tissue. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Xiaoying Sun, Xinxing Wan, Md Asaduzzaman Khan, Keke Zhang, Xuan Yi, Zhouqi Wang, Ke Chen
Comprehensive Analysis of circRNA Expression Profiles in Human Brown Adipose Tissue. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Keke Zhang, Xinxing Wan, Md Asaduzzaman Khan, Xiaoying Sun, Xuan Yi, Zhouqi Wang, Ke Chen, Lin Peng
Peripheral Blood circRNA Microarray Profiling Identities hsa_circ_0001831 and hsa_circ_0000867 as Two Novel circRNA Biomarkers for Early Type 2 Diabetic Nephropathy. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Xinxing Wan, Liyong Zhu, Liling Zhao, Lin Peng, Jing Xiong, Wenjun Yang, Jingjing Yuan, Fang Liang, Keke Zhang, Ke Chen
hPER3 promotes adipogenesis via hHSP90AA1-mediated inhibition of Notch1 pathway. Cell death & disease 12 (4) (2021)